Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
Department of Hepatobiliary and Transplant Surgery, St James' University Hospital, Leeds LS9 7TF, UK.
Department of Hepatobiliary and Pancreatic Surgery, Queen's Medical Centre, Derby Road, Nottingham NG7 2UH, UK.
Department of Hepatobiliary and Transplant Surgery, St James' University Hospital, Leeds LS9 7TF, UK. Electronic address: [email protected]
- Published Article
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
- Publication Date
Aug 01, 2014
NRH is not an uncommon finding amongst patients with SOS with all patients having received oxaliplatin-based chemotherapy. Data on outcome would suggest no increased morbidity and mortality associated with the presence of NRH.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 06/09/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/24370284